IP Library Granted Patent US 10,182,862
Granted Patent B2
US 10,182,862 · App. 15/970,428 · Granted Jan 22, 2019

Method and device for uterine fibroid treatment

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,182,862
App. No.
15/970,428
Granted
Jan 22, 2019
Kind
B2
Abstract

Methods and devices for both imaging and treating uterine fibroid tumors in one real-time system are provided. One minimally invasive method comprises introducing a sheath into a uterus and determining a location of a fibroid using a visualization element within or on the sheath. Upon identification, a portion of the sheath is steered to position at least one treatment needle at the determined location. The needle is then anchored in uterine tissue and the fibroid treated with the needle.

Claims (24)

1. A method for minimally invasive treatment of tissue of a bodily cavity or organ, said method comprising:

providing a probe having a longitudinal axis;

determining a location of target tissue using a visualization element within or on the probe, wherein both the visualization element and an imaging field are deflectable with respect to the longitudinal axis of the probe;

advancing a first needle including a plurality of second needles from the probe across the imaging field;

advancing the plurality of second needles from the first needle into the target tissue; and

treating the target tissue with the plurality of second needles;

wherein determining the location of the target tissue comprises rotating the visualization element and the imaging field about the longitudinal axis of the probe independently of the plurality of second needles.

2. A method as in claim 1 , wherein the probe is introduced transcervically.

3. A method as in claim 1 , wherein the visualization element is ultrasonic and produces a visual image.

4. A method as in claim 3 , further comprising manually positioning and penetrating the plurality of second needles through an epithelium so as to engage the target tissue.

5. A method as in claim 1 , wherein the plurality of second needles remain within the limits of the imaging field during treatment.

6. A method as in claim 5 , wherein treating the target tissue comprises delivering ablative energy to the target tissue with the one or more second needles of the plurality of second needles.

7. A method as in claim 6 , wherein the ablative energy comprises radiofrequency energy, microwave energy, laser energy, cryo energy, ultrasound energy, HIFU, or radiation.

8. A method as in claim 7 , wherein the ablative energy comprises radiofrequency energy delivered in a bipolar or monopolar fashion.

9. A method as in claim 5 , wherein treating the target tissue comprises delivering at least one therapeutic agent to the target tissue with the one or more second needles of the plurality of second needles.

10. A method as in claim 1 , further comprising imaging needle anchoring and treatment in real-time with the visualization element.

11. A method as in claim 1 , further comprising monitoring tissue impedance.

12. A method as in claim 1 , further comprising measuring a tissue temperature so as to aid in diagnosis, blood supply measurement, thermal signature, or tissue targeting.

13. A method as in claim 1 , wherein the visualization element produces the imaging field and the imaging field is transverse to the longitudinal axis of the probe.

14. A method as in claim 1 , wherein the first needle is advanced through a wall of the bodily cavity or organ.

15. A method as in claim 1 , wherein the first needle is hollow.

16. A method as in claim 1 , wherein the plurality of second needle diverge from one another when advanced from the first needle.

17. A method as in claim 1 , wherein the bodily cavity or organ comprises a uterus.

18. A method as in claim 1 , wherein the target tissue comprises at least one uterine fibroid.

Assignments (3)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 070236/0154 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: GYNESONICS, INC.
Reel/Frame 075455/0789 →
SECURITY INTEREST Recorded Feb 14, 2025
From: GYNESONICS, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 070236/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2018
From: GROSSMAN, JESSICA
To: GYNESONICS, INC.
Reel/Frame 047388/0076 →
Cited By (6)
US 12,350,097 US 12,414,813 US 12,507,986 US 12,514,536 US 12,690,839 US 12,697,187